Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Revenue of Outset Medical, Inc. (OM)
Revenue in 2023 (TTM): $130.38 M
According to Outset Medical, Inc.'s latest financial reports the company's current revenue (TTM) is $130.38 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Outset Medical, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $130.38 M | $29 M | $-153,789,000 | $-172,274,000 | $-172,797,000 |
| 2022 | $115.38 M | $17.83 M | $-152,812,000 | $-162,661,000 | $-162,956,000 |
| 2021 | $102.6 M | $7.61 M | $-124,859,000 | $-131,736,000 | $-131,935,000 |
| 2020 | $49.94 M | $-13,037,000 | $-114,846,000 | $-121,492,000 | $-120,698,000 |
| 2019 | $15.08 M | $-17,802,000 | $-62,087,000 | $-68,279,000 | $-68,299,000 |
| 2018 | $2.01 M | $-6,115,000 | $-43,622,000 | $-49,755,000 | $-49,780,000 |